Here we report a pediatric patient with relapsed and refractory AML with RAN-binding protein 2 (RANBP2)-ALK fusion with monosomy 7, who achieved complete remission (CR) after treatment with crizotinib and allogeneic hematopoietic cell transplantation (allo-HCT). Here, ALK is linked to acute myeloid leukemia.